PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: AnaSpec, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

AnaSpec Inc. Introduces Eleven New Peptides - This week AnaSpec, a world leader in custom and catalog peptides, introduced eleven (11) new peptides
AnaSpec Inc. Introduces Eleven New Peptides

 

NewswireToday - /newswire/ - San Jose, CA, United States, 2008/06/16 - This week AnaSpec, a world leader in custom and catalog peptides, introduced eleven (11) new peptides.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

[dAla2,Cys4]Deltorphin C- Cat# 62680
This deltorphin C (or deltorphin 1) peptide modification is a selective agonist at the supraspinal opioid delta-1 receptor subtype in mouse. It was evaluated in an anti-nociceptive assay after i.c.v. administration to mice. It was shown to produce dose-related anti-nociceptive effects.
Sequence: YaFCVVG-NH2

Deltorphin A- Cat# 62682
Deltorphin A peptide was isolated from skin extracts of the South American frog, Phyllomedusa sauvagei. Deltorphin A is a potent and selective agonist for the delta-opioid receptor.
Sequence: YmFHLMD-NH2

CMV EP 88, Cytomegalovirus Early Protein pp89 Derivative, YPHFMPTNL,- Cat# 62781
This peptide is processed from the immediate early protein pp89 of mouse cytomegalovirus (CMV). It is presented to CD8+ T lymphocytes by the H-2 Ld molecule. Infection of mice with murine CMV leads to CD8 cell responses to this immunodominant epitope. This peptide was employed in vaccines development.
Sequence: YPHFMPTNL

CHK1tide, 5-TAMRA labeled- Cat# 62807-1
This is checkpoint kinase CHK1 substrate labeled with TAMRA. CHK1 is an evolutionarily conserved protein kinase that has been implicated in cell cycle checkpoint control in lower eukaryotes. Chk1 plays an essential role in the mammalian DNA damage checkpoint, embryonic development, and tumor suppression.
Sequence: TAMRA-ALKLVRYPSFVITAK-NH2

CHK1tide, 5-TAMRA labeled- Cat# 62807-5
This is checkpoint kinase CHK1 substrate labeled with TAMRA. CHK1 is an evolutionarily conserved protein kinase that has been implicated in cell cycle checkpoint control in lower eukaryotes. Chk1 plays an essential role in the mammalian DNA damage checkpoint, embryonic development, and tumor suppression.
Sequence: TAMRA-ALKLVRYPSFVITAK-NH2

CHK1tide, FAM labeled- Cat# 62806-1
This is checkpoint kinase CHK1 substrate labeled with 5-FAM. CHK1 is an evolutionarily conserved protein kinase that has been implicated in cell cycle checkpoint control in lower eukaryotes. Chk1 plays an essential role in the mammalian DNA damage checkpoint, embryonic development, and tumor suppression.
Sequence: FAM-ALKLVRYPSFVITAK-NH2

CHK1tide, FAM labeled- Cat# 62806-5
This is checkpoint kinase CHK1 substrate labeled with 5-FAM. CHK1 is an evolutionarily conserved protein kinase that has been implicated in cell cycle checkpoint control in lower eukaryotes. Chk1 plays an essential role in the mammalian DNA damage checkpoint, embryonic development, and tumor suppression.
Sequence: FAM-ALKLVRYPSFVITAK-NH2

Neurotensin- Cat# 62677
This 13 amino acid peptide was first isolated from bovine hypothalamus and was named from its neuronal localization. It was detected in the central nervous system (CNS) and peripheral tissues mainly in the gastrointestinal tract. This bioactive form of neurotensin post-translationally modified at a Glu residue was isolated from porcine intestine. In the CNS, neurotensin has dual function of neuromodulator of dopamine transmission and of anterior pituitary hormone secretion. It also shows potent hypothermic and analgesic effects in the brain. Neurotensin has been implicated in the pathophysiology of schizophrenia, Huntington, and Parkinson diseases.
Sequence: QLYENKPRRPYIL

Leucokinin II, Myokinin II, Anopheles- Cat# 62768
This peptide belongs to the Anopheles leucokinin II. Insect leucokinins elicit potent diuretic effects on the Malpighian tubules of insects, and contraction of the hindgut hence the alternative term “myokinin.” This is the shortest of all three Anopheles leucokinins, with the sequence identical to culekinin I, and Aedes leucokinin II.
Sequence: NPFHSWG-NH2

MAGE-3 (114-127)- Cat# 62702
This is amino acids 114 to 127 fragment of the MAGE-3 protein. Among the MAGE genes, MAGE-3 is one of the most frequently expressed in tumors. For instance, it is expressed in 76% of metastatic melanomas. This peptide binds to HLA molecules and hence could be a target antigen for an antitumor CTL response.
Sequence: AELVHFLLLKYRAR

MAGE-3 (121-134)- Cat# 62701
This is amino acids 121 to 134 fragment of the MAGE-3 protein. MAGE-type genes are expressed by many tumors of different histological types and not by normal cells, except for male germline cells. Therefore, the antigens encoded by MAGE-type genes are strictly tumor specific and common to many tumors. This peptide is presented by the HLA-DR13 molecule which is expressed in 20% of XCaucasians.
Sequence: LLKYRAREPVTKAE

About AnaSpec, Inc.

AnaSpec, Inc. (anaspec.com) is a leading provider of integrated proteomics solutions to pharmaceutical, biotech, and academic research institutions throughout the world. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents, and combinatorial chemistry. Established in 1993, AnaSpec's headquarters and manufacturing facilities are located in San Jose, CA.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: AnaSpec, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


AnaSpec Inc. Introduces Eleven New Peptides

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Ping Yang 
408-452-5055 ping[.]anaspec.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any AnaSpec, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From AnaSpec, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)